JobanVaishnavMD

Heart Failure & Transplantation

Physician

Dr. Vaishnav is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

MD State Medical License 2017 - 2025
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Advanced Heart Failure and Transplant Cardiology
American Board of Internal Medicine Cardiovascular Disease

A Study of AT-02 in Subjects With Systemic Amyloidosis. Start of enrollment: 2023 Sep 21
Recruiting
Phase 2
Roles: Contact
Study of AT-02 in Healthy Volunteers and Subjects With Systemic Amyloidosis Start of enrollment: 2022 Sep 01
Recruiting
Phase 1
Roles: Contact

PubMed

Transthyretin Cardiac Amyloidosis: Increasing Evidence of the Benefits of A TTRansformation in Diagnostic and Treatment Strategies.
Joban D Vaishnav, Farooq H Sheikh
Journal of Cardiac Failure. 2024-09-01
1 citations
Race and Socioeconomic Status Impact Diagnosis and Clinical Outcomes in Transthyretin Cardiac Amyloidosis.
Bairavi Shankar, Lisa Yanek, Artrish Jefferson, Vivek Jani, Emily Brown
JACC. Cardiooncology. 2024-06-01
1 citations
The Cardiac Amyloidosis Registry Study (CARS): Rationale, Design and Methodology.
Lily K Stern, Justin L Grodin, Mathew S Maurer, Frederick L Ruberg, Ayan R Patel
Journal of Cardiac Failure. 2024-05-01

Journal Articles

Clinical Research Randomized Evaluation of Heart Failure with Preserved Ejection Fraction Patients with Acute Heart Failure and Dopamine: The ROPA-DOP Trial
Joban Vaishnav, David A Kass, Kavita Sharma, Nishant Shah, Allison Tsao, John Miller, Richa Gupta, David R Thiemann, Rohan Kalathiya, Steven P Schulman, Stuart D Russe..., ScienceDirect